Inhibition of LOX1 by Statins May Relate to Upregulation of eNOS (original) (raw)
Vascular effects of HMG CoA-reductase inhibitors (statins) unrelated to cholesterol lowering: new concepts for cardiovascular disease
David Lefer
Cardiovascular Research, 2001
View PDFchevron_right
Statins Modulate Oxidized Low-Density Lipoprotein-Mediated Adhesion Molecule Expression in Human Coronary Artery Endothelial Cells: Role of LOX-1
Tom Saldeen
Journal of Pharmacology and Experimental Therapeutics, 2002
View PDFchevron_right
Anti-atherogenic effect of statins: role of nitric oxide, peroxynitrite and haem oxygenase-1
T. Malinski
British Journal of Pharmacology, 2009
View PDFchevron_right
The effects of statins on endothelium, inflammation and cardioprotection
David Lefer
Drug News & Perspectives, 2005
View PDFchevron_right
Oxidized LDL through LOX1 increases the expression of angiotensin converting enzyme in human coronary artery endothelial cells
Robin Singh
Journal of The American College of Cardiology, 2002
View PDFchevron_right
HMG-CoA Reductase Inhibitors Regulate Inflammatory Transcription Factors in Human Endothelial and Vascular Smooth Muscle Cells
Otmar Pachinger, Matthias Frick
Arteriosclerosis, Thrombosis, and Vascular Biology, 2003
View PDFchevron_right
Endothelial Dysfunction, Oxidative Stress and Inflammation: Implications in Atherogenesis, Cardiovascular Diseases and Gene Targeted Therapeutic Approach
Olamide O Crown
Journal of Pharmacology and Toxicology, 2023
View PDFchevron_right
Statins in atherosclerosis: lipid-lowering agents with antioxidant capabilities
Robert Rosenson
Atherosclerosis, 2004
View PDFchevron_right
Cardiac effects of statins—advancements and open questions
M. Bohm
Cardiovascular Research, 2005
View PDFchevron_right
Impact of Statins in Ischemic Heart Disease
Karunakaran Gauthaman
2011
View PDFchevron_right
Direct vascular and cardioprotective effects of rosuvastatin, a new HMG-CoA reductase inhibitor
David Lefer
Journal of the American College of Cardiology, 2002
View PDFchevron_right
Pleiotropic effects of statins: A boulevard to cardioprotection
Aakash Deep
Arabian Journal of Chemistry, 2016
View PDFchevron_right
Statins and Oxidative Stress During Atherogenesis
Alberico Catapano
European Journal of Cardiovascular Prevention & Rehabilitation, 2003
View PDFchevron_right
Endothelial Protection, AT1 Blockade and Cholesterol-Dependent Oxidative Stress: The EPAS Trial
Volker Adams
Circulation, 2006
View PDFchevron_right
Nitric oxide synthase II (NOS II) gene expression correlates with atherosclerotic intimal thickening. Preventive effects of HMG-CoA reductase inhibitors
Jose Alfon
Atherosclerosis, 1999
View PDFchevron_right
Basic science review: Statin therapy--Part I: The pleiotropic effects of statins in cardiovascular disease
Benjamin Sadowitz
Vascular and endovascular surgery, 2010
View PDFchevron_right
Rapid, Direct Effects of Statin Treatment on Arterial Redox State and Nitric Oxide Bioavailability in Human Atherosclerosis via Tetrahydrobiopterin-Mediated Endothelial Nitric Oxide Synthase Coupling
Michael Demosthenous
Circulation, 2011
View PDFchevron_right
Statins: 3Hydroxy3-methylglutaryl-CoA (HMG-CoA) Reductase Inhibitors Demonstrate AntiAtherosclerotic Character due to Their Antioxidant Capacity
Mohan Dhale
Applied Biochemistry and Biotechnology, 2011
View PDFchevron_right
Different Effect of Statins on Platelet Oxidized-LDLReceptor (CD36 and LOX-1) Expressionin Hypercholesterolemic Subjects
Alberto Palazzuoli
Clinical and Applied Thrombosis/Hemostasis, 2005
View PDFchevron_right
The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals
William Sessa
Nature medicine, 2000
View PDFchevron_right
Can modulation of endothelial nitric oxide synthase explain the vasculoprotective actions of statins?
William Sessa
Trends in molecular medicine, 2001
View PDFchevron_right
Statin mediated protection of the ischemic myocardium
David Lefer
Vascular Pharmacology, 2005
View PDFchevron_right
Statins, HMG-CoA Reductase Inhibitors, Improve Neovascularization by Increasing the Expression Density of CXCR4 in Endothelial Progenitor Cells
Chih-Ting Lin
PLOS ONE, 2015
View PDFchevron_right
Statins stimulate atherosclerosis and heart failure: pharmacological mechanisms
Yoichi Ogushi
Expert review of clinical pharmacology, 2015
View PDFchevron_right
Effect of HMG-CoA Reductase Inhibition on Endothelial Dysfunction-Inducing Protein in Hypercholesterolemic Rabbits
juan david cardona gomez
Revista Espanola De Cardiologia, 2002
View PDFchevron_right
3-Hydroxy-3-methylglutaryl coenzyme a (HMG-CoA) reductase inhibitors (statins), atherosclerosis and coronary syndromes
Neta Blum
Atherosclerosis, 2004
View PDFchevron_right
The evolving role of statins in the management of atherosclerosis
carl vaughan
Journal of the American College of Cardiology, 2000
View PDFchevron_right
Statins as Pleiotropic Modifiers of Vascular Oxidative Stress and Inflammation
Michael Koutsilieris
The Journal of Critical Care Medicine, 2015
View PDFchevron_right
Statins exert endothelial atheroprotective effects via the KLF2 transcription factor
H. Larman, Vinod Nambudiri, Guohao Dai
View PDFchevron_right
Antioxidant effects of statins in the management of cardiometabolic disorders
Soo Lim
Journal of atherosclerosis and thrombosis, 2014
View PDFchevron_right
Recent development in the effects of statins on cardiovascular disease through Rac1 and NADPH oxidase
Sze Ma
Vascular Pharmacology, 2013
View PDFchevron_right
Statins: targeting cardiovascular disease
Frederick Raal
SA heart, 2017
View PDFchevron_right
HMG-CoA Reductase Inhibition: Anti-Inflammatory Effects beyond Lipid Lowering?
Heinrich Wieland
European Journal of Cardiovascular Prevention & Rehabilitation, 2003
View PDFchevron_right
Anti-atherogenic effects of statins: Impact on angiopoietin-2 release from endothelial cells
Andreas Hoeft, Sven Klaschik, Stilla Frede
Biochemical Pharmacology, 2013
View PDFchevron_right
Statins Control Oxidized LDL-Mediated Histone Modifications and Gene Expression in Cultured Human Endothelial Cells
Hortense Slevogt
Arteriosclerosis, Thrombosis, and Vascular Biology, 2009
View PDFchevron_right